Popular Articles

La Jolla Institute Discovers Novel Tumor Suppressor
La Jolla Institute for Allergy and Immunology researchers studying an enzyme believed to play a role in allergy onset, instead have discovered its previously unknown role as a tumor suppressor that may be important in myeloproliferative diseases and some types of lymphoma and leukemia. Myeloproliferative diseases are a group of disorders characterized by an overproduction of blood cells by the bone marrow and include chronic myeloid leukemia. Lymphoma and leukemia are cancers of the blood.
drugs without prescription
Animal TB "Tracker" To Speed Drug And Vaccine Studies
Johns Hopkins researchers have developed a novel way to monitor in real time the behavior of the TB bacterium in mouse lungs noninvasively pinpointing the exact location of Mycobacterium tuberculosis. The new monitoring system is expected to speed up what is currently a slow and cumbersome process to test the safety and efficacy of various TB drug regimens and vaccines in animals. Plans are already under way for developing a similar system to monitor TB disease in humans.
News of the day
AP/Los Angeles Times Examines Haiti's Fight Against HIV
The AP/Los Angeles Times examines Haiti"s success at reducing the number of people infected with HIV/AIDS in the country through the work of the "nonprofit groups, Boston-based Partners in Health (PIH) and Port-au-Prince"s GHESKIO, widely considered to be the world"s oldest AIDS clinic." Haiti"s HIV rate is "lower than the Bahamas, Guyana and Suriname, and much lower than sub-Saharan Africa, where the rate averages about 5 percent but spikes to 24 percent in Botswana and 33 percent in Swaziland," according to the newspaper. Still, as the article notes, Haiti"s "crisis is far from over," with varying infection rates across remote regions in the country.

Send email

Send email:
Your message:
Your name/organization:
Your E-mail:
Enter today\\'s date, 2 digits
(spam protection):